Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib.
Leukemia
; 30(6): 1405-9, 2016 06.
Article
in En
| MEDLINE
| ID: mdl-26511402
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein-Tyrosine Kinases
/
Fusion Proteins, bcr-abl
/
Protein Kinase Inhibitors
/
Imidazoles
/
Indazoles
Type of study:
Diagnostic_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Leukemia
Year:
2016
Document type:
Article